# Lyell Immunopharma, Inc.: Form 8-K/A, filed Jan 10, 2025

- Company: [Lyell Immunopharma, Inc.](/companies/lyel.md) (CIK 1806952)
- Form: 8-K/A
- Filed: 2025-01-10
- Accepted by EDGAR: Jan 10, 2025, 14:10 ET
- Period: 2024-10-31
- Accession: 0001628280-25-001065
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1806952/000162828025001065/lyel-20241031.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1806952/000162828025001065/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1806952/000162828025001065/lyel-20241031.htm

Filed Jan 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-001065. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.